$TLPH News

Talphera, Inc. (TLPH) Q1 2026 Earnings Call Transcript

Talphera Q1 2026 Earnings Call Transcript

Talphera Q1 EPS $(0.04) Beats $(0.07) Estimate, Sales $0.00 Down From $27.000K YoY

WestPark Capital Initiates Coverage On Talphera with Buy Rating, Announces Price Target of $3

Talphera, Inc. (TLPH) Analyst/Investor Day Transcript

Talphera Q4 EPS $(0.06) Beats $(0.14) Estimate

Talphera Announces 50% Patient Enrollment Of NEPHRO-CRRT Clinical Trial

This Talphera Insider Increased Their Holding By 138% Last Year

Talphera (TLPH) Q3 2025 Earnings Call Transcript

Talphera shares are trading lower. The company reported Q3 financial results.

Talphera shares are trading lower. The company reported Q3 financial results.

Talphera Inc (TLPH) Q3 2025 Earnings Call Highlights: Strategic Investments and Regulatory ...

Talphera: Q3 Earnings Snapshot

Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Talphera, Inc. (TLPH) Q3 2025 Earnings Call Transcript

Talphera Q3 EPS $(0.11) Beats $(0.13) Estimate, Sales $1.000K

CorMedix Inc. Reports Third Quarter 2025 Financial Results and Updates FY 2025 Guidance

Earnings Outlook For Talphera

Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025

Talphera Granted CorMedix Exclusive Right Of First Negotiation For Potential Acquisition Of Co. With 60 Day Exclusive Negotiation Period Following Completion And Announcement Of Phase 3 Niyad Study Results And Right To Nominate One Member To Talphera's Board